Musk's Neuralink Chip To Embark on Its First Clinical Trial
- September 22, 2023
- 2:30 PM CDT
- Amy Mays
Elon Musk’s startup Neuralink is set to embark on its first ever clinical trial.
The company announced on Tuesday that it was accepting interested individuals who would like to offer themselves for recruitment. Neuralink was given approval by the Federal Drug Authority in May to implant microchips in human brains.
Startup Seeks People For Brain-Implant
Elon Musk’s Neuralink is now looking for people to join its initial human experiment. A robot will assist in placing a brain-computer interface, allowing individuals to manage a computer cursor or type solely through their thoughts.
Individuals who are 22-year-old and have quadriplegia due to spinal cord injury or amyotrophic lateral sclerosis, the company said.
Critics
A robot will be used to put in a brain-computer connection that allows them to move a computer pointer or type by just thinking.
Neuralink’s aim with these human tests is to one day let someone with paralysis operate a computer or phone solely using their thoughts. Opponents have raised ethical concerns about Elon Musk’s startup but they don’t seem to make any difference amid the hype.
本文地址：http://www.panshare.cn/news/99174.html
版权声明
本文仅代表作者观点，不代表本站立场。
本文系作者授权发表，未经许可，不得转载。